Harrow announced the appointments of Adrienne Graves, Ph.D., and Lauren Silvernail to the Company?s Board of Directors, effective immediately. Harrow?s Board now consists of six members. Dr. Adrienne.
Revance Therapeutics (NASDAQ:RVNC) Price Target Cut to $10.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Revance Therapeutics (NASDAQ:RVNC – Get Free Report) had its price target decreased by analysts at Barclays from $35.00 to $10.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has an “overweight” rating on the biopharmaceutical company’s stock. Barclays‘s price objective would suggest a potential upside of 68.92% […]
Analysts Set Revance Therapeutics, Inc. (NASDAQ:RVNC) Target Price at $22.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.